• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation

Before Header

Association of National Account Executives

Connect - Convene - Collaborate

  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

Kodak’s stock triples as company announces pandemic plan to start making pharmaceutical ingredients

The Trump administration’s $765 million loan to the Eastman Kodak Co. for its launch of a business making pharmaceutical ingredients sent shares of the iconic camera company soaring. 

The Trump administration said the Kodak deal is the first of its kind and uses powers afforded by the Defense Production Act.

The administration previously used these powers to demand that Ford Motor Co. begin manufacturing respirators and masks and that General Motors Co. make ventilators. 
Read More
Previous Post: « New Learning Module on U.S. Healthcare Supply Chain Available
Next Post: The Path Forward: Healthcare Reimagined in the Context of Inequality »
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

Copyright © 2026 Association of National Account Executives · All Rights Reserved · Powered by Mai Theme